Longboard Pharmaceuticals, Inc. (LBPH) Financial Statements (2024 and earlier)

Company Profile

Business Address 4275 EXECUTIVE SQUARE
LA JOLLA, CA 92037
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:63,000,00076,100,00067,600,00077,300,00087,400,00096,100,000
Cash and cash equivalents19,504,00025,121,00010,775,00018,745,00027,716,00035,037,000
Short-term investments43,543,00051,005,00056,814,00058,574,00059,702,00061,087,000
Other undisclosed cash, cash equivalents, and short-term investments(47,000)(26,000)11,000(19,000)(18,000)(24,000)
Other undisclosed current assets2,592,0002,860,0002,238,0002,492,0002,746,0004,059,000
Total current assets:65,592,00078,960,00069,838,00079,792,00090,146,000100,159,000
Noncurrent Assets
Operating lease, right-of-use asset589,000681,000736,000824,000355,000438,000
Property, plant and equipment7,0008,0009,00010,00012,00013,000
Long-term investments and receivables35,00035,00033,00033,000 33,000
Long-term investments35,00035,00033,00033,000 33,000
Total noncurrent assets:631,000724,000778,000867,000367,000484,000
TOTAL ASSETS:66,223,00079,684,00070,616,00080,659,00090,513,000100,643,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,498,0001,351,0001,800,0002,993,0002,966,0003,336,000
Employee-related liabilities1,589,0001,019,000443,000
Accounts payable1,939,000283,0001,310,000575,000602,0001,357,000
Accrued liabilities559,0001,068,000490,000829,0001,345,0001,536,000
Other undisclosed current liabilities5,403,0005,888,0006,964,0005,160,0004,578,0003,348,000
Total current liabilities:7,901,0007,239,0008,764,0008,153,0007,544,0006,684,000
Noncurrent Liabilities
Long-term debt and lease obligation:    469,000 94,000
Liabilities, other than long-term debt214,000312,000382,000   
Operating lease, liability214,000312,000382,000469,000 94,000
Total noncurrent liabilities:214,000312,000382,000938,000 188,000
Total liabilities:8,115,0007,551,0009,146,0009,091,0007,544,0006,872,000
Equity
Equity, attributable to parent58,108,00072,133,00061,470,00072,037,00082,969,00093,865,000
Common stock2,0002,0001,0001,0001,0001,000
Additional paid in capital170,993,000170,150,000148,303,000147,748,000146,953,000146,254,000
Accumulated other comprehensive loss(290,000)(421,000)(692,000)(915,000)(784,000)(596,000)
Accumulated deficit(112,597,000)(97,598,000)(86,142,000)(74,797,000)(63,201,000)(51,794,000)
Total equity:58,108,00072,133,00061,470,00072,037,00082,969,00093,865,000
Other undisclosed liabilities and equity    (469,000) (94,000)
TOTAL LIABILITIES AND EQUITY:66,223,00079,684,00070,616,00080,659,00090,513,000100,643,000

Income Statement (P&L) (USD)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Operating expenses(15,642,000)(11,962,000)(11,727,000)(11,884,000)(11,567,000)(9,620,000)
Operating loss:(15,642,000)(11,962,000)(11,727,000)(11,884,000)(11,567,000)(9,620,000)
Loss from continuing operations:(15,642,000)(11,962,000)(11,727,000)(11,884,000)(11,567,000)(9,620,000)
Loss before gain (loss) on sale of properties:(11,884,000)(11,567,000)(9,620,000)
Other undisclosed net income  506,000382,000  23,000
Net loss:(15,642,000)(11,456,000)(11,345,000)(11,884,000)(11,567,000)(9,597,000)
Other undisclosed net income attributable to parent643,000  288,000160,000 
Net loss available to common stockholders, diluted:(14,999,000)(11,456,000)(11,345,000)(11,596,000)(11,407,000)(9,597,000)

Comprehensive Income (USD)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(15,642,000)(11,456,000)(11,345,000)(11,884,000)(11,567,000)(9,597,000)
Comprehensive loss:(15,642,000)(11,456,000)(11,345,000)(11,884,000)(11,567,000)(9,597,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent774,000271,000223,000157,000(28,000)(432,000)
Comprehensive loss, net of tax, attributable to parent:(14,868,000)(11,185,000)(11,122,000)(11,727,000)(11,595,000)(10,029,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: